OxyElite Issues Recall Following Liver Illness Outbreak

November 19, 2013

Important Information

ClassAction.org is no longer reviewing claims for this case. The information here is for reference only. Up-to-date information and resources can be found here.

Comments |

At A Glance

This Alert Affects
Individuals who took certain dietary supplements labeled OxyElite Pro.
Damages
Acute hepatitis, liver failure/damage, acute liver failure, liver transplant, hospitalization or death.
Company(ies)
USPlabs LLC
Additional Details
Fever, fatigue, nausea, loss of appetite, vomiting, abdominal pain, dark urine, clay-colored bowel movements, joint pain, yellow eyes, and jaundice may be early signs of liver damage or failure in acute hepatitis patients.
Date
On November 9, 2013, the FDA announced that USPlabs would be voluntarily recalling several OxyElite products after reports of a dangerous link between liver injuries and the dietary supplement surfaced in Hawaii.
Type of Lawsuit
Mass Tort